metastatic Cancer of the Gastroesophageal Junction (GEJ)

DBCOND0173127Neoplasms

metastatic Cancer of the Gastroesophageal Junction (GEJ) is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Classified under: Neoplasms
Indicated drugs: Hyaluronidase (human recombinant)
Nivolumab

What you can answer from here — as of October 23, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

Which approved drugs for metastatic Cancer of the Gastroesophageal Junction (GEJ) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account